In smaller transactions, ARK sold shares of Adaptive Biotechnologies Corp (NASDAQ: ADPT) and CareDx Inc (NASDAQ: CDNA ), and bought shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Veracyte Inc ...

Illumina, a next-generation DNA sequencing company, has called off its plans to buy nascent competitor Pacific Biosciences of California. Some of the banks that helped fuel the fracking boom are ...

Illumina Inc. ILMN reported first-quarter 2025 adjusted earnings per share (EPS) of 97 cents, which topped the Zacks ...

The global Single Cell Analysis Market , valued at US$3.55 billion in 2024, is forecasted to grow at a robust CAGR of 14.7%, ...

Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses.

Brent Kendall is the Law Bureau Chief for The Wall Street Journal. A longtime legal affairs reporter, he has covered the Supreme Court and lower courts across the country, as well as the Justice ...

Find out how genome sequencing has emerged and what the future holds for one of biotech's most important tools.

For the study, they used instruments from Illumina, PacBio, Oxford Nanopore, and Element Biosciences. The participants in the study are a Utah family that has worked with genetic researchers ...

Join ABC Australia and ABC Radio Australia for the funeral of Pope Francis, live from St Peter's Square. Witness centuries of tradition as Jeremy Fernandez presents Special Coverage of this ...

The CLOE Spring Symposium 'Origins of genes, proteins and animals' will be held on April 23rd, 2pm-4pm in the JZ Young LT, Med & Anatomy Building. This seminar is open to all regardless of career ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

This initiative will leverage PacBio's advanced sequencing technology to generate genetic insights that can guide future research, prevention, and treatment efforts. Vaibhav Narayan, Executive ...